NU-DESMOPRESSIN SPRAY METERED-DOSE PUMP

Страна: Канада

мова: англійська

Джерело: Health Canada

Активний інгредієнт:

DESMOPRESSIN ACETATE

Доступна з:

NU-PHARM INC

Код атс:

H01BA02

ІПН (Міжнародна Ім'я):

DESMOPRESSIN

Дозування:

0.1G

Фармацевтична форма:

METERED-DOSE PUMP

Склад:

DESMOPRESSIN ACETATE 0.1G

Адміністрація маршрут:

NASAL

Одиниць в упаковці:

2.5ML/5ML

Тип рецепту:

Prescription

Терапевтична области:

PITUITARY

Огляд продуктів:

Active ingredient group (AIG) number: 0112050008; AHFS:

Статус Авторизація:

CANCELLED (UNRETURNED ANNUAL)

Дата Авторизація:

2018-03-28

Характеристики продукта

Page 1 of 20
PRODUCT MONOGRAPH
PR
NU-DESMOPRESSIN SPRAY, 10 ΜG/SPRAY
(DESMOPRESSIN ACETATE NASAL SOLUTION)
ANTIDIURETIC
NU-PHARM INC.
DATE OF PREPARATION:
50 MURAL STREET, UNITS 1 & 2
OCTOBER 14, 2009
RICHMOND HILL, ONTARIO
L4B 1E4
CONTROL#: 133359
Page 2 of 20
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION....................................................... 3
SUMMARY PRODUCT INFORMATION
..................................................................................
3
INDICATIONS AND CLINICAL
USE........................................................................................
3
WARNINGS AND
PRECAUTIONS............................................................................................
3
ADVERSE
REACTIONS..............................................................................................................
6
DRUG INTERACTIONS
..............................................................................................................
7
DOSAGE AND
ADMINISTRATION..........................................................................................
7
OVERDOSAGE
............................................................................................................................
8
ACTION AND CLINICAL PHARMACOLOGY
........................................................................
9
STORAGE AND
STABILITY....................................................................................................
10
DOSAGE FORMS, COMPOSITION AND PACKAGING
....................................................... 11
PART II: SCIENTIFIC INFORMATION
.............................................................................
12
PHARMACEUTICAL
INFORMATION....................................................................................
12
CLINICAL
TRIALS....................................................................................................................
13
TOXICOLOGY
.................................................................................................